Sekiyama Kazunari

セキヤマカズナリ | Sekiyama Kazunari

Affiliation and department：
Job title： Researcher

Research field (1)： Veterinary medicine

Research keywords (2)：分化・増殖因子 , Differentiation ・ Growth Factor

Research theme for competitive and other funds (3)：

2013 - 2016 Adiponectin, anti diabetic adipokine, as a novel therapeutic strategy for synucleinopathies.
2003 - 2009 アクチビンβEサブユニット
2003 - 2009 Activin βE Subunit

Papers (31)：

Kazunari Sekiyama, Yuuki Ushiro, Akira Kurisaki, Masayuki Funaba, Osamu Hashimoto. Activin E enhances insulin sensitivity and thermogenesis by activating brown/beige adipocytes. The Journal of veterinary medical science. 2019. 81. 5. 646-652
Osamu Hashimoto, Masayuki Funaba, Kazunari Sekiyama, Satoru Doi, Daichi Shindo, Ryo Satoh, Hiroshi Itoi, Hiroaki Oiwa, Masahiro Morita, Chisato Suzuki, et al. Activin E Controls Energy Homeostasis in Both Brown and White Adipose Tissues as a Hepatokine. Cell reports. 2018. 25. 5. 1193-1203
Masaaki Waragai, Gilbert Ho, Yoshiki Takamatsu, Kazunari Sekiyama, Shuei Sugama, Takato Takenouchi, Eliezer Masliah, Makoto Hashimoto. Importance of adiponectin activity in the pathogenesis of Alzheimer's disease. Annals of clinical and translational neurology. 2017. 4. 8. 591-600
Shuei Sugama, Kazunari Sekiyama, Tohru Kodama, Yoshiki Takamatsu, Takato Takenouchi, Makoto Hashimoto, Bruno Conti, Yoshihiko Kakinuma. Corrigendum to "Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson's disease" [Brain Behav. Immun. 51 (2016) 39-46]. Brain, behavior, and immunity. 2017. 61. 389-389
Yoshiki Takamatsu, Gilbert Ho, Wakako Koike, Shuei Sugama, Takato Takenouchi, Masaaki Waragai, Jianshe Wei, Kazunari Sekiyama, Makoto Hashimoto. Combined immunotherapy with "anti-insulin resistance" therapy as a novel therapeutic strategy against neurodegenerative diseases. NPJ Parkinson's disease. 2017. 3. 4-4

ｍore...

MISC (17)：

新井信隆, 小島利香, 関山一成, 江口弘美, 山西常美, 八木朋子, 植木信子, 関絵里香. 学習効率を向上させるデジタル神経病理実習の運用. 日本病理学会会誌. 2019. 108. 1. 439-440
関絵里香, 小島利香, 関山一成, 江口弘美, 植木信子, 八木朋子, 新井信隆. 中枢神経系の診断力向上への取組み・デジタル教育ツールの利用. 日本病理学会会誌. 2019. 108. 1. 440-440
高松芳樹, 関山一成, 井上聡, 本多芳子, 児玉亨, 橋本款. レビー小体型認知症で同定された2種類の変異型βシヌクレイン(P123H、V70M)は、ショウジョウバエ脳において異なるメカニズムで神経変性を引き起こす. 日本生化学会大会・日本分子生物学会年会合同大会講演要旨集. 2015. 88回・38回. [3P1251]-[3P1251]
関山一成, 橋本款. 【パーキンソン病とαシヌクレイン】シヌクレイントランスジェニックマウス. 細胞. 2015. 47. 1. 16-19
関山一成, 高松芳樹, 橋本款. 【遺伝子・再生医療研究から学ぶパーキンソン病】PARK遺伝子研究の現状【α-synuclein(PARK1/4)】αシヌクレインの生理作用. 医学のあゆみ. 2013. 247. 10. 999-1002

ｍore...

Professional career (1)：

獣医学博士 (北里大学大学院)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page